In this fifteen minute video, join Shurjeel Choudhri MD, FRCPC Senior Vice President and Head, Medical & Scientific Affairs, Bayer Inc., as he takes the stage at the CATA Gala to discuss ” Using Technology to Accelerate Better Healthcare Outcomes.” A Slide Presentation is also provided.
Dr. Choudhri was joined by Ohad Arazi, Chief Strategy Officer, Vice President Provider Solutions, TELUS Health as co keynote at the CATA Innovation Gala. Their presentations are complimentary.
Senior Vice President and Head, Medical and Scientific Affairs
Dr. Choudhri is the Head of Medical and Scientific Affairs (M&SA) for Bayer Inc. He joined Bayer Corporation in 1999 and has had significant experience with the Bayer US and Global medical organizations. Before assuming his current role as Head of M&SA in Canada, Dr. Choudhri was a Global Clinical Leader, Anti-Infectives with Bayer Global Clinical Development.
Prior to joining Bayer, Dr. Choudhri was an assistant professor in the Departments of Medical Microbiology and Internal Medicine at the University of Manitoba in Winnipeg. He was also the director of the AIDS program at the St. Boniface General Hospital in Winnipeg; and the Manitoba satellite director for the Canadian HIV Clinical Trials Network.
Dr. Choudhri obtained his MD and also did his specialty training in internal medicine and sub-specialty training in infectious diseases at the University of Manitoba. Following completion of his training, he completed a senior research fellowship in Nairobi, Kenya. In 1996, he was awarded the Young Investigator Award by the Canadian Association of HIV Researchers. Dr. Choudhri has authored or co-authored over 100 scientific abstracts and has contributed to over 30 publications in peer reviewed journals. He is a passionate advocate for mobile and digital Health and is a member of the Canadian Advanced Technology Alliance (CATA) mobile health advisory board. Dr. Choudhri has played an active role in the creation of the Canadian Clinical Trials Asset Map and is a member of the Canadian Clinical Trials Coordinating Centre executive committee.
The Canadian Advanced Technology Alliance (CATAAlliance), Canada’s One Voice for Innovation Lobby Group and ‘political party’ for Canada’s tech industry, crowdsources ideas and guidance from thousands of opt in members in moderated social networks in Canada and key global markets. Supported by evidence-based research, CATAAlliance then mobilizes the community behind public policy recommendations designed to boost Canada’s innovation and competitiveness success.